re: "will be completed in July 2020"
I noticed that too, and it's a similar end-date for the MJFF et al. trial. Maybe it's based on an expected slow recruitment process? All the more reason to get these announcements and articles spread around the PwP communities and forums. |
Quote:
|
Quote:
I do agree, we should all get the word out about the upcoming trial recruitment and cut the 6 month time down to one month. If that happens with both cohorts we can cut almost a year off of the study time. |
Enrollment Now Open for Nilotinib Clinical Trial in Parkinson’s
Enrollment opened today for the MJFF-funded Phase IIa clinical trial to test the safety and tolerability of nilotinib in Parkinson’s disease.
The trial will investigate the potential of repurposing nilotinib (which many in the patient community know is an FDA-approved treatment for cancer of the white blood cells) in Parkinson’s. Learn more about recruiting sites and eligibility criteria on our website and download our guide on what patients and families should know about repurposed therapies. Best, Debi |
All times are GMT -5. The time now is 03:41 AM. |
Powered by vBulletin Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.
vBulletin Optimisation provided by
vB Optimise v2.7.1 (Lite) -
vBulletin Mods & Addons Copyright © 2024 DragonByte Technologies Ltd.